Table 4

Differences in Adherence Using MAQ and Pill Count, Primary Endpoint in Phase 2

ControlPolypillp Value
Intention-to-treat
 9-month visit + pill count (80%–110%) + Morisky = 20n = 345n =350
 Adherence141 (41%)178 (50.8%)0.019
Per protocol
 All visits + pill count (80%–110%) + Morisky = 20n = 219n = 239
 Adherence122 (55.7%)157 (65.7%)0.012

MAQ = Morisky-Green questionnaire.